1. Home
  2. STRT vs IFRX Comparison

STRT vs IFRX Comparison

Compare STRT & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$81.26

Market Cap

282.6M

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.07

Market Cap

86.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
IFRX
Founded
1908
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.6M
86.0M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
STRT
IFRX
Price
$81.26
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
53.9K
909.6K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
45.55
N/A
EPS
5.73
N/A
Revenue
$578,413,000.00
$73,729.00
Revenue This Year
$4.15
N/A
Revenue Next Year
$4.12
$1,075.42
P/E Ratio
$14.10
N/A
Revenue Growth
6.83
N/A
52 Week Low
$31.57
$0.71
52 Week High
$83.07
$2.77

Technical Indicators

Market Signals
Indicator
STRT
IFRX
Relative Strength Index (RSI) 67.86 42.44
Support Level $77.08 $1.00
Resistance Level $81.29 $1.12
Average True Range (ATR) 3.71 0.09
MACD 0.54 -0.01
Stochastic Oscillator 90.20 36.09

Price Performance

Historical Comparison
STRT
IFRX

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: